[1] 陈喜林, 苏航, 仲凯励, 达永, 肖秀斌, 刘静, 余金德, 张伟京, CHEN Xi-Lin, SU Hang, ZHONG Kai-Li, DA Yong, XIAO Xiu-Bin, HU Jing, YU Jing-De, ZHANG Wei-Jing. 自体外周血造血干细胞联合自体骨髓移植治疗难治性淋巴瘤的临床分析 [J]. 中国实验血液学杂志 2009. [2] 王华庆, 崔秀珍, 任秀宝, 刘贤明, 戴荣增, 张会来, 黄文阳, 李维, 郝希山. 自体造血干细胞移植联合大剂量放化疗治疗恶性淋巴瘤56例临床分析 [J]. 中华医学杂志 2003.doi:10.3760/j:issn:0376-2491.2003.11.013 [3] 汪颖, 吴德沛, 吴小津, 徐杨, 孙爱宁, 仇惠英. 自体造血干细胞移植治疗T细胞淋巴瘤20例疗效分析 [J]. 苏州大学学报(医学版) 2010. [4] Espigado, I, Rios, E, Marin-Niebla, A, Carmona, M, Parody, R, Perez-Hurtado, JM, Marquez, FJ, Urbano-Ispizua, A. High rate of long-term survival for high-risk lymphoma patients treated with hematopoietic stem cell transplantation as consolidation or salvage therapy. [J]. Transplantation Proceedings 2008, 9(9). [5] Espigado I, Rios E, Marin Niebla A. High rate of long-term survival for high-risk lymphoma patients treated with hematopoietic stem cell transplantation as consolidation or salvage therapy. [J]. Transplantation Proceedings 2008, 9(9). [6] Naparstek E. [J]. Current hematology reports 2005. |